aptar is a leading global supplier of a broad range of innovative dispensing systems for the beauty, personal care, home care, prescription drug, consumer health care, injectables, food, and beverage markets. aptar is headquartered in crystal lake, illinois, with manufacturing facilities in north america, europe, asia and south america. for more information, visit www.aptar.com.
Company profile
Ticker
ATR
Exchange
Website
CEO
Stephan Tanda
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
APTARGROUP INC
SEC CIK
Corporate docs
Subsidiaries
AptarGroup International L.L.C. • Seaquist Canada Ltd. • Asia Pacific Inspection Center (Suzhou) Co., Ltd. • AIGE LLC • Healthcare, Inc. • Healthcares HK Limited • Aptar Services S.A.S. • AptarGroup International Holding S.a.r.l. • Aptar Ventures LLC • Aptar Queretaro S.A. de C.V. ...
IRS number
363853103
ATR stock data
Latest filings (excl ownership)
ARS
2023 FY
Annual report to shareholders
22 Mar 24
DEFA14A
Additional proxy soliciting materials
22 Mar 24
DEF 14A
Definitive proxy
22 Mar 24
PRE 14A
Preliminary proxy
8 Mar 24
S-3ASR
Automatic shelf registration
9 Feb 24
10-K
2023 FY
Annual report
9 Feb 24
8-K
Aptar Reports Fourth Quarter and Annual 2023 Results
8 Feb 24
10-Q
2023 Q3
Quarterly report
26 Oct 23
8-K
Aptar Reports Third Quarter 2023 Results
25 Oct 23
8-K
Amendments to Articles of Incorporation or Bylaws
13 Oct 23
Transcripts
ATR
Earnings call transcript
2023 Q4
9 Feb 24
ATR
Earnings call transcript
2023 Q3
26 Oct 23
ATR
Earnings call transcript
2023 Q2
28 Jul 23
ATR
Earnings call transcript
2023 Q1
28 Apr 23
ATR
Earnings call transcript
2022 Q4
17 Feb 23
ATR
Earnings call transcript
2022 Q3
28 Oct 22
ATR
Earnings call transcript
2022 Q2
29 Jul 22
ATR
Earnings call transcript
2022 Q1
29 Apr 22
ATR
Earnings call transcript
2021 Q4
18 Feb 22
ATR
Earnings call transcript
2021 Q3
29 Oct 21
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Institutional ownership, Q3 2023
88.4% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 413 |
Opened positions | 43 |
Closed positions | 46 |
Increased positions | 150 |
Reduced positions | 145 |
13F shares | Current |
---|---|
Total value | 7.33 tn |
Total shares | 58.47 mm |
Total puts | 5.10 k |
Total calls | 1.70 k |
Total put/call ratio | 3.0 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 7.15 mm | $893.56 bn |
BLK Blackrock | 5.99 mm | $749.24 bn |
State Farm Mutual Automobile Insurance | 4.74 mm | $593.26 bn |
MS Morgan Stanley | 4.61 mm | $576.24 bn |
STT State Street | 3.09 mm | $386.65 bn |
Victory Capital Management | 1.84 mm | $229.89 bn |
Rivulet Capital | 1.65 mm | $206.50 bn |
Boston Trust Walden | 1.42 mm | $177.17 bn |
FMR | 1.37 mm | $171.45 bn |
Neuberger Berman | 1.30 mm | $162.20 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
22 Mar 24 | Stephan B. Tanda | Common Stock | Payment of exercise | Dispose F | No | No | 141.59 | 2,144 | 303.57 k | 163,956 |
22 Mar 24 | Robert Kuhn | Common Stock | Payment of exercise | Dispose F | No | No | 141.59 | 550 | 77.87 k | 62,948 |
22 Mar 24 | Vinczeller Shiela | Common Stock | Payment of exercise | Dispose F | No | No | 141.59 | 212 | 30.02 k | 22,511 |
22 Mar 24 | Kimberly Chainey | Common Stock | Payment of exercise | Dispose F | No | No | 141.59 | 284 | 40.21 k | 7,906 |
22 Mar 24 | Gong Xiangwei | Common Stock | Payment of exercise | Dispose F | No | No | 141.59 | 357 | 50.55 k | 19,287 |
News
Wells Fargo Maintains Overweight on AptarGroup, Raises Price Target to $160
7 Mar 24
AptarGroup Q4 2023 Adj EPS $1.21 Beats $1.12 Estimate, Sales $838.48M Miss $842.50M Estimate
8 Feb 24
Earnings Scheduled For February 8, 2024
8 Feb 24
Tuesday Is Your Last Chance To Buy AptarGroup Before The Dividend Payout
26 Jan 24
Press releases
Aptar Declares Quarterly Dividend
11 Apr 24
Aptar Named a CDP Supplier Engagement Leader for the Fourth Consecutive Year
20 Mar 24
Aptar Named One of Barron's 100 Most Sustainable U.S. Companies for the Sixth Consecutive Year
29 Feb 24
Aptar Signs Enterprise Agreement with Biogen to Operate and Develop Digital Health Solutions
9 Feb 24
Aptar Reports Fourth Quarter and Annual 2023 Results
8 Feb 24